RNA · Atrium Therapeutics, Inc. · Debt
Market Cap
$177.04M
Shares
17.11M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
2093101
CUSIP
04965N104
13F (30d)
91 filings
91 filers
Visit website
Investor relations